• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The SYNTAX trial: a perspective.

作者信息

Gulati Rajiv, Rihal Charanjit S, Gersh Bernard J

机构信息

Department of Medicine, Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minn 55905, USA.

出版信息

Circ Cardiovasc Interv. 2009 Oct;2(5):463-7. doi: 10.1161/CIRCINTERVENTIONS.109.882670.

DOI:10.1161/CIRCINTERVENTIONS.109.882670
PMID:20031757
Abstract
摘要

相似文献

1
The SYNTAX trial: a perspective.SYNTAX 试验：一种观点。
Circ Cardiovasc Interv. 2009 Oct;2(5):463-7. doi: 10.1161/CIRCINTERVENTIONS.109.882670.
2
The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase.紫杉醇药物洗脱支架冠状动脉介入治疗与心脏手术协同作用（SYNTAX）研究：设计、原理及导入阶段
Am Heart J. 2006 Jun;151(6):1194-204. doi: 10.1016/j.ahj.2005.07.017.
3
Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.经皮冠状动脉介入治疗的最新进展：药物洗脱支架的演变，聚焦于XIENCE V药物洗脱支架。
Coron Artery Dis. 2010 Jan;21(1):46-56. doi: 10.1097/MCA.0b013e328333f550.
4
Current percutaneous coronary intervention and coronary artery bypass grafting practices for three-vessel and left main coronary artery disease. Insights from the SYNTAX run-in phase.当前针对三支血管病变及左主干冠状动脉疾病的经皮冠状动脉介入治疗和冠状动脉旁路移植术实践。来自SYNTAX导入期的见解。
Eur J Cardiothorac Surg. 2006 Apr;29(4):486-91. doi: 10.1016/j.ejcts.2006.01.047. Epub 2006 Feb 23.
5
Polymer-based paclitaxel-eluting stents in percutaneous coronary intervention: a review of the TAXUS trials.经皮冠状动脉介入治疗中基于聚合物的紫杉醇洗脱支架：TAXUS试验综述
J Interv Cardiol. 2004 Oct;17(5):271-82. doi: 10.1111/j.1540-8183.2004.04040.x.
6
[Drug-eluting stents for diabetic patients. A critical appraisal of the currently available data from randomized trials].[糖尿病患者的药物洗脱支架。对随机试验现有数据的批判性评估]
Herz. 2008 Apr;33(3):196-205. doi: 10.1007/s00059-008-3121-5.
7
[Left main coronary stenting is safe and effective and is a valuable alternative to coronary artery bypass graft surgery].
G Ital Cardiol (Rome). 2009 Feb;10(2):113-7; discussion 117.
8
Percutaneous coronary intervention in perspective: drug-eluting stents as a model for regulatory review.经皮冠状动脉介入治疗的前景：药物洗脱支架作为监管审查的一个范例
Circ Cardiovasc Interv. 2009 Dec;2(6):574-9. doi: 10.1161/CIRCINTERVENTIONS.109.871996.
9
[Drug-eluting stents in multivessel coronary artery disease: Was one of the important fortresses of surgery conquered?].[药物洗脱支架用于多支冠状动脉疾病：手术的重要堡垒之一被攻克了吗？]
Anadolu Kardiyol Derg. 2009 Aug;9(4):325-30.
10
Percutaneous intervention in saphenous vein bypass graft disease: case against the use of drug-eluting stents.隐静脉旁路移植血管病变的经皮介入治疗：反对使用药物洗脱支架的案例
J Am Coll Cardiol. 2008 Mar 4;51(9):970-1; author reply 971-2. doi: 10.1016/j.jacc.2007.08.068.

引用本文的文献

1
Recent Advances in Coronary Chronic Total Occlusions.冠状动脉慢性完全闭塞的最新进展
J Clin Med. 2025 Feb 25;14(5):1535. doi: 10.3390/jcm14051535.
2
Impact of Hierarchy on Multidisciplinary Heart-Team Recommendations in Patients with Isolated Multivessel Coronary Artery Disease.层级制度对孤立性多支冠状动脉疾病患者多学科心脏团队建议的影响
J Clin Med. 2019 Sep 19;8(9):1490. doi: 10.3390/jcm8091490.
3
Distribution of Thoracic Aortic Calcifications in Patients Undergoing Coronary Artery Bypass Grafting.接受冠状动脉旁路移植术患者的胸主动脉钙化分布
Aorta (Stamford). 2017 Oct 1;5(5):132-138. doi: 10.12945/j.aorta.2017.17.035. eCollection 2017 Oct.
4
Patient preferences for coronary artery bypass graft surgery or percutaneous intervention in multivessel coronary artery disease.多支冠状动脉疾病患者对冠状动脉旁路移植术或经皮介入治疗的偏好。
Catheter Cardiovasc Interv. 2013 Aug 1;82(2):212-8. doi: 10.1002/ccd.24399. Epub 2013 May 6.